Last edition
News about Industrial talks
Indian Pharmacopoeia Commission (IPC) hosts the Indian Pharmacopoeia (IP) 2026 Scientific Conclave and Interactive Session, focusing on medicine quality, impurity standards, regulatory science, and patient safety.
Industrial talks | 16/05/2026 | By News Bureau | 127
Avid Bioservices Names Kerri McCullough Wood Chief Commercial Officer
Avid Bioservices appoints Kerri McCullough Wood as Chief Commercial Officer (CCO) to lead global commercial strategy and accelerate growth across early- and late-phase biologics programs.
Industrial talks | 12/05/2026 | By News Bureau
NIPER Raebareli Signs CDA and Tech Transfer Pact with Lofty Laboratories
NIPER Raebareli signs CDA and technology transfer agreement with Lofty Laboratories to advance indigenous technology commercialisation in biotechnology sector.
Industrial talks | 11/05/2026 | By News Bureau
Viatris Appoints Paul Campbell as Interim Chief Financial Officer
Viatris announces Chief Financial Officer (CFO) transition as Theodora “Doretta” Mistras departs and Paul Campbell is named interim CFO, ensuring leadership continuity.
Industrial talks | 05/05/2026 | By News Bureau | 112
Addex Therapeutics Reports Promising Preclinical Results for Novel Chronic Cough Therapy
Addex Therapeutics’ experimental GABAB modulator shows potential as a well-tolerated, long-term treatment option for chronic cough, addressing a significant unmet need in idiopathic pulmonary fibrosis patients.
Industrial talks | 04/05/2026 | By News Bureau
European Medicines Agency Launches Advisory Group to Tackle Vaccine Hesitancy
‘European Medicines’ Advisory Group aims to rebuild public trust, strengthen vaccine communication and counter misinformation across Europe.
Industrial talks | 02/05/2026 | By News Bureau
Syngene Strengthens Leadership Team with Two Key Appointments
Maninder Kapoor Puri joins Syngene as Chief Human Resources Officer (CHRO) and Abhijit Zutshi as Chief Commercial Officer (CCO)
Industrial talks | 01/05/2026 | By News Bureau | 124
US FDA Recommends AstraZeneca's TRUQAP for PTEN-Deficient Prostate Cancer
US Food and Drug Administration (FDA) advisory panel backs TRUQAP (capivasertib) with abiraterone and ADT for PTEN-deficient metastatic hormone-sensitive prostate cancer, based on positive phase 3 CAPItello-281 results showing favorable benefit-risk.
Industrial talks | 01/05/2026 | By News Bureau
TESARO Provides Update on AnaptysBio Litigation
TESARO Inc., part of GlaxoSmithKline plc, provides an update on litigation with AnaptysBio Inc., reaffirming its declaratory judgment claim and intent to pursue the case at trial.
Industrial talks | 28/04/2026 | By News Bureau
Indian Institute of Technology Kanpur appoints Prof. Anil K. Lalwani as Inaugural Dean of Gangwal School of Medical Sciences & Technology, strengthening innovation in digital health, medical robotics, and affordable healthcare solutions.
Industrial talks | 22/04/2026 | By News Bureau | 147
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy